QuickLogic Corporation , a leading provider of embedded FPGA (eFPGA) Hard IP, and ruggedized FPGAs, today announced the integration of the Synopsys Synplify® synthesis tool into its FPGA User Tools.

MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment ...

Empire is based at 40 Wall Street, New York, New York, United States of America. Empire has been engaged for a period of three months, effective February 7, 2025 (the “ Empire Agreement ”). Pursuant ...

Quantum BioPharma TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a ...

Quantum BioPharma Ltd. has announced the retention of Enterprise Canada Inc. and Empire Market Ventures, LLC to enhance its public relations and investor awareness programs in key markets.

Can-Fite BioPharma Ltd. has announced an upcoming investor webinar scheduled for February 25, 2025, at 4:15 p.m. ET, hosted by RedChip Companies. The session will feature insights from Can-Fite's ...

(Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Accord BioPharma Inc., the U.S. specialty division of Intas Pharmaceuticals Ltd., has reached an exclusive commercialization and license agreement with Bio-Thera Solutions for BAT2506, a biosimilar ...